Published • loading... • Updated
Circulogene Expands Solid Tumor Genomic Capabilities with Launch of OncoGenDx Tissue Assay
Summary by TBNweekly
14 Articles
14 Articles

+13 Reposted by 13 other sources
Circulogene Expands Solid Tumor Genomic Capabilities with Launch of OncoGenDx Tissue Assay
PENSACOLA, Fla., Oct. 7, 2025 /PRNewswire/ -- Circulogene today announced the national launch of OncoGenDx, an innovative tissue-based comprehensive genomic profiling (CGP) assay that delivers expanded insights into all solid tumors. Designed to complement Circulogene's existing portfolio—including OncoGenLDx, the industry's…
Coverage Details
Total News Sources14
Leaning Left1Leaning Right0Center4Last UpdatedBias Distribution80% Center
Bias Distribution
- 80% of the sources are Center
80% Center
L 20%
C 80%
Factuality
To view factuality data please Upgrade to Premium